ASCO 2012: Post-Progression Erlotinib in NSCLC
Dr. Mark Vincent, London Health Sciences Centre, presents highlights from:
Lung Cancer - Non-small Cell Metastatic General Poster Session, Post-progression erlotinib in NSCLC, at ASCO 2012.
Written by Simon Ashdown on June 22, 2012